Crunchbase is the main destination for millions of users to discover industry trends, investments, and news from startups to Fortune 1000 global companies.
Clair Labs, a remote patient monitoring company, received $9 million in seed funding to continue developing contactless technologies for hospitals and home healthcare.
The leading seed round was 10D, with participants including SleepScore Ventures, Maniv Mobility and Vasuki.
Adi Berenson and Ran Margolin co-founded the Israeli company in 2018 after meeting Apple, and they are members of its product incubation team.
After seeing the aging population and the hospital’s push to send low-vision patients home, they thought of Claire’s laboratory, which led to more high-vision patients in the hospital. At home, patients usually get medical equipment, and the two believe that they can combine Apple’s consumer technology knowledge with healthcare to make these devices easier to use and are devices that patients are willing to use at home.
The result is non-contact biomarker sensing for continuous monitoring of vital signs, including heart rate, respiration, airflow, and body temperature. Clair Labs is using this information to build medical devices and systems.
“One of the challenges in this field is that it is very broad, and there are many companies that take a horizontal approach,” Berenson told Crunchbase News. “We think the best way is to find the existing workflow and deploy our technology. It’s a bit tricky because you have to fall into existing clinical, regulatory, and reimbursement practices, but when all of these are in place, it will work good.”
The company’s initial goals were sleep medicine, especially sleep apnea, and acute and post-acute care facilities.
According to Berenson, biomarker sensing is a more cost-effective all-weather digital monitoring method. The system also monitors behavioral markers, including sleep patterns and pain, and tracks changes in the patient’s position, such as the intention to get up. All of this data is analyzed through machine learning algorithms to provide assessments and alerts to healthcare professionals.
The technology is currently undergoing clinical trials in Israel, and the company plans to start trials in sleep centers and hospitals in the United States.
Clair Labs is pre-paid and operated in a lean team composed of 10 employees. The new funding will enable the company to recruit staff for its R&D center in Tel Aviv and enable it to open a US office next year, which will focus primarily on providing customer support and leading marketing and sales in North America.
“It took us some time to incubate, but in this round, we are now moving from the incubation phase to the prototype design and clinical trials phase,” Berenson said. “The trials are progressing smoothly and the system is working well. Our goals for the next two years include completing trials in Israel, obtaining FDA approval, and starting sales before we proceed to the next round of financing.”
At the same time, Rotem Eldar, the managing partner of 10D, stated that his company’s focus is on digital health. Because the experienced team brings technology and expertise into areas with huge market opportunities, people have a strong interest in Clair Labs. interest.
In the past few months, several remote patient monitoring companies have attracted venture capital, including:
Eldar said that Clair Labs is unique in its computer vision expertise, and it does not have to develop new sensors-which is a huge burden for the company-as non-contact applications in different clinical applications.
He added: “Although sleep testing is a niche market, it is a fast and needed market entry.” “With this type of sensor, they can quickly enter the market and easily expand their use to other application.”
Post time: Jun-22-2021